Fact CheckerSign in

NCT07232719Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

A Phase 3b Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial

Source: ClinicalTrials.gov · Last updated 17 Apr 2026

Brief summary (registry, in English)

The purpose of this study is to evaluate the efficacy and safety of retatrutide compared with placebo for body weight reduction. Participation in the study will last about 65 weeks and may include about 18 visits.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
250 (estimated)
First submitted
14 Nov 2025
Start date
17 Nov 2025
Primary completion date
Jul 2027
Lead sponsor
Eli Lilly and Company
NCT number
NCT07232719

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 250
  • From 17 Nov 2025 to the primary completion date, Jul 2027
  • 31 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have a self-reported change in body weight \>5 kg (11 pounds) within 90 days before screening
  • Have a prior or planned surgical treatment for obesity
  • Have had within the past 90 days before screening
    • acute myocardial infarction
    • cerebrovascular accident (stroke)
    • hospitalization for unstable angina, or
    • hospitalization due to congestive heart failure
  • Have taken weight loss drugs, including over-the counter medications within 90 days prior to screening

Other illness

  • Have type 1 diabetes or type 2 diabetes
  • Have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2)
  • Have New York Heart Association Functional Classification Class IV congestive heart failure
  • Have a history of chronic or acute pancreatitis

Who the study is looking for

  • Have a body mass index (BMI) of:
    • ≥30 kilogram per square meter (kg/m2) OR
    • ≥27 kg/m2 with at least one of the following weight-related conditions: high blood pressure, abnormal levels of lipid, obstructive sleep apnea, heart disease
  • Have at least one unsuccessful attempt to lose weight by dieting

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (31)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
FutureMeds - Birmingham
Coordinator of this site? Confirm its status
BirminghamUnited KingdomUnknown status
Layton Medical Centre
Coordinator of this site? Confirm its status
BlackpoolUnited KingdomUnknown status
Bradford on Avon Health Centre
Coordinator of this site? Confirm its status
Bradford on AvonUnited KingdomUnknown status
FutureMeds - Liverpool
Coordinator of this site? Confirm its status
BromboroughUnited KingdomUnknown status
Cheadle Community Hospital
Coordinator of this site? Confirm its status
CheadleUnited KingdomUnknown status
HMC Health Group - Meadows Centre for Health
Coordinator of this site? Confirm its status
HounslowUnited KingdomUnknown status
St Bartholomew's Medical Centre
Coordinator of this site? Confirm its status
OxfordUnited KingdomUnknown status
Atlantic Medical
Coordinator of this site? Confirm its status
PenzanceUnited KingdomUnknown status
The Adam Practice
Coordinator of this site? Confirm its status
PooleUnited KingdomUnknown status
Woodstock Bower Surgery
Coordinator of this site? Confirm its status
RotherhamUnited KingdomUnknown status
Rame Group Practice
Coordinator of this site? Confirm its status
TorpointUnited KingdomUnknown status
Albany House Medical Centre
Coordinator of this site? Confirm its status
WellingboroughUnited KingdomUnknown status
Care Access - Arlington Heights
Coordinator of this site? Confirm its status
Arlington HeightsUnited StatesUnknown status
JEM Research Institute
Coordinator of this site? Confirm its status
AtlantisUnited StatesUnknown status
Pharmasite Research, Inc.
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status
Clinical Research Professionals
Coordinator of this site? Confirm its status
ChesterfieldUnited StatesUnknown status
Cedar Health Research
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status
Headlands Research-El Paso
Coordinator of this site? Confirm its status
El PasoUnited StatesUnknown status
Cedar Health Research - Euless
Coordinator of this site? Confirm its status
EulessUnited StatesUnknown status
Cedar Health Research - Fort Worth
Coordinator of this site? Confirm its status
Fort WorthUnited StatesUnknown status
Care Access - Houston
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
L-MARC Research Center
Coordinator of this site? Confirm its status
LouisvilleUnited StatesUnknown status
IMA Clinical Research Monroe - Armand
Coordinator of this site? Confirm its status
MonroeUnited StatesUnknown status
Ima Clinical Research Manhattan
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
Headlands Research Orlando
Coordinator of this site? Confirm its status
OrlandoUnited StatesUnknown status
Artemis Institute for Clinical Research
Coordinator of this site? Confirm its status
RiversideUnited StatesUnknown status
IMA Clinical Research San Antonio
Coordinator of this site? Confirm its status
San AntonioUnited StatesUnknown status
Clinvest Headlands LLC
Coordinator of this site? Confirm its status
SpringfieldUnited StatesUnknown status
Care Access - Tamarac
Coordinator of this site? Confirm its status
TamaracUnited StatesUnknown status
IMA Clinical Research Warren
Coordinator of this site? Confirm its status
Warren TownshipUnited StatesUnknown status
Trial Management Associates - Wilmington - Floral Parkway
Coordinator of this site? Confirm its status
WilmingtonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.